Candidate genes of Waldenström’s macroglobulinemia: current evidence and research

References

• GhobrialIMGertzMAFonsecaRWaldenström macroglobulinaemiaLancet Oncol200341167968514602248
   PubMed Web of Science ®Google Scholar
• KyleRAAndersonKCA tribute to Gosta WaldenströmBlood19978912424542479192746
   PubMed Web of Science ®Google Scholar
• OwenRGTreonSPAl-KatibAClinicopathological definition of Waldenstrom’s macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom’s MacroglobulinemiaSemin Oncol200330211011512720118
   PubMed Web of Science ®Google Scholar
• RajkumarSVDispenzieriAKyleRAMonoclonal gammopathy of undetermined significance, Waldenström macroglobulinemia, AL amyloidosis, and related plasma cell disorders: diagnosis and treatmentMayo Clin Proc200681569370316706268
   PubMed Web of Science ®Google Scholar
• KriangkumJTaylorBJTreonSPMantMJBelchARPilarskiLMClonotypic IgM V/D/J sequence analysis in Waldenstrom macroglobulinemia suggests an unusual B-cell origin and an expansion of polyclonal B cells in peripheral bloodBlood200410472134214214764523
   PubMed Web of Science ®Google Scholar
• DimopoulosMAPanayiotidisPMoulopoulosLASfikakisPDalakasMWaldenström’s macroglobulinemia: clinical features, complications, and managementJ Clin Oncol200018121422610623712
   PubMed Web of Science ®Google Scholar
• American Cancer SocietyCancer Facts and Figures 2012AtlantaAmerican Cancer Society2012 Available from: http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-031941.pdfAccessed March 12, 2013
   Google Scholar
• FonsecaRHaymanSWaldenström macroglobulinaemiaBr J Haematol2007138670072017672883
   PubMed Web of Science ®Google Scholar
• GertzMAKyleRANoelPPrimary systemic amyloidosis: a rare complication of immunoglobulin M monoclonal gammopathies and Waldenström’s macroglobulinemiaJ Clin Oncol19931159149208487054
   PubMed Web of Science ®Google Scholar
• GhobrialIMFonsecaRGertzMAPrognostic model for disease-specific and overall mortality in newly diagnosed symptomatic patients with Waldenstrom macroglobulinaemiaBr J Haematol2006133215816416611306
   PubMed Web of Science ®Google Scholar
• MorelPDuhamelAGobbiPInternational prognostic scoring system for Waldenstrom macroglobulinemiaBlood2009113184163417019196866
   PubMed Web of Science ®Google Scholar
• AnsellSMKyleRAReederCBDiagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelinesMayo Clin Proc201085982483320702770
   PubMed Web of Science ®Google Scholar
• SaccoALeleuXRossiGGhobrialIMRoccaroAMNovel agents in Waldenström MacroglobulinemiaOpen J Hematol20101pii2
   Google Scholar
• BurwickNRoccaroAMLeleuXGhobrialIMTargeted therapies in Waldenström macroglobulinemiaCurr Opin Investig Drugs200896631637
   Google Scholar
• SaccoAGhobrialIMRoccaroAMAnti-angiogenic therapies in the treatment of Waldenstrom’s MacroglobulinemiaCurr Cancer Drug Targets20111191025102921933107
   PubMed Web of Science ®Google Scholar
• GertzMAWaldenström macroglobulinemia: 2011 update on diagnosis, risk stratification, and managementAm J Hematol201186541141621523800
   PubMed Web of Science ®Google Scholar
• SchopRFJalalSMVan WierSADeletions of 17p13.1 and 13q14 are uncommon in Waldenström macroglobulinemia clonal cells and mostly seen at the time of disease progressionCancer Genet Cytogenet20021321556011801310
   PubMedGoogle Scholar
• KristinssonSYBjörkholmMGoldinLRMcMasterMLTuressonILandgrenORisk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in SwedenBlood200811283052305618703425
   PubMed Web of Science ®Google Scholar
• GoldinLRBjörkholmMKristinssonSYTuressonILandgrenOHighly increased familial risks for specific lymphoma subtypesBr J Haematol20091461919419438470
   PubMed Web of Science ®Google Scholar
• LiangXSCaporasoNMcMasterMLCommon genetic variants in candidate genes and risk of familial lymphoid malignanciesBr J Haematol2009146441842319573080
   PubMed Web of Science ®Google Scholar
• KyleRATherneauTMRajkumarSVLong-term follow-up of IgM monoclonal gammopathy of undetermined significanceBlood2003102103759376412881316
   PubMed Web of Science ®Google Scholar
• KyleRADispenzieriAKumarSLarsonDTherneauTRajkumarSVIgM monoclonal gammopathy of undetermined significance (MGUS) and smoldering Waldenström’s macroglobulinemia (SWM)Clin Lymphoma Myeloma Leuk2011111747621454195
   PubMed Web of Science ®Google Scholar
• PreussKDHeldGKubuschokBIdentification of antigenic targets of paraproteins by expression cloning does not support a causal role of chronic antigenic stimulation in the pathogenesis of multiple myeloma and MGUSInt J Cancer2007121245946117373665
   PubMed Web of Science ®Google Scholar
• PreussKDPfreundschuhMAhlgrimmMA frequent target of paraproteins in the sera of patients with multiple myeloma and MGUSInt J Cancer2009125365666119405124
   PubMed Web of Science ®Google Scholar
• GrassSPreussKDWikowiczAHyperphosphorylated paratarg-7: a new molecularly defined risk factor for monoclonal gammopathy of undetermined significance of the IgM type and Waldenstrom macroglobulinemiaBlood2011117102918292321220746
   PubMed Web of Science ®Google Scholar
• GrassSPreussKDAhlgrimmMAssociation of a dominantly inherited hyperphosphorylated paraprotein target with sporadic and familial multiple myeloma and monoclonal gammopathy of undetermined significance: a case-control studyLancet Oncol2009101095095619767238
   PubMed Web of Science ®Google Scholar
• BraggioEKeatsJJLeleuXHigh-resolution genomic analysis in Waldenström’s macroglobulinemia identifies disease-specific and common abnormalities with marginal zone lymphomasClin Lymphoma Myeloma200991394219362969
   PubMedGoogle Scholar
• ChangHSamieeSLiDPattersonBChenCIStewartAKAnalysis of IgH translocations, chromosome 13q14 and 17p13.1(p53) deletions by fluorescence in situ hybridization in Waldenstrom’s macroglobulinemia: a single center study of 22 casesLeukemia20041861160116215103388
   PubMed Web of Science ®Google Scholar
• TerréCNguyen-KhacFBarinCTrisomy 4, a new chromosomal abnormality in Waldenström’s macroglobulinemia: a study of 39 casesLeukemia20062091634163616838026
   PubMed Web of Science ®Google Scholar
• McMasterMLGoldinLRBaiYGenomewide linkage screen for Waldenstrom macroglobulinemia susceptibility loci in high-risk familiesAm J Hum Genet200679469570116960805
   PubMed Web of Science ®Google Scholar
• Nguyen-KhacFLambertJChapiroEChromosomal aberrations and their prognostic value in a series of 174 untreated patients with Waldenstrom macroglobulinemiaHaematologica Epub10122012
   Web of Science ®Google Scholar
• GutiérrezNCOcioEMde Las RivasJGene expression profiling of B lymphocytes and plasma cells from Waldenström’s macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individualsLeukemia200721354154917252022
   PubMed Web of Science ®Google Scholar
• ChngWJSchopRFPrice-TroskaTGene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myelomaBlood200610882755276316804116
   PubMed Web of Science ®Google Scholar
• HeinrichPCBehrmannIHaanSHermannsHMMüller-NewenGSchaperFPrinciples of interleukin (IL)-6-type cytokine signalling and its regulationBiochem J2003374Pt 112012773095
   PubMed Web of Science ®Google Scholar
• HideshimaTChauhanDHayashiTProteasome inhibitor PS-341 abrogates IL-6 triggered signaling cascades via caspase-dependent downregulation of gp130 in multiple myelomaOncogene200322528386839314627979
   PubMed Web of Science ®Google Scholar
• JourdanMVeyruneJLDe VosJRedalNCoudercGKleinBA major role for Mcl-1 antiapoptotic protein in the IL-6-induced survival of human myeloma cellsOncogene200322192950295912771946
   PubMed Web of Science ®Google Scholar
• UchiyamaHBarutBAMohrbacherAFChauhanDAndersonKCAdhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretionBlood19938212371237208260708
   PubMed Web of Science ®Google Scholar
• ElsawaSFNovakAJZiesmerSCComprehensive analysis of tumor microenvironment cytokines in Waldenstrom macroglobulinemia identifies CCL5 as a novel modulator of IL-6 activityBlood2011118205540554921921047
   PubMed Web of Science ®Google Scholar
• HodgeLSAnsellSMJak/Stat pathway in Waldenström’s macroglobulinemiaClin Lymphoma Myeloma Leuk201111111211421454207
   PubMed Web of Science ®Google Scholar
• HodgeLSZiesmerSCYangZZIL-21 in the bone marrow microenvironment contributes to IgM secretion and proliferation of malignant cells in Waldenstrom macroglobulinemiaBlood2012120183774378222976953
   PubMed Web of Science ®Google Scholar
• OcioEMSchopRFGonzalezB6q deletion in Waldenström macroglobulinemia is associated with features of adverse prognosisBr J Haematol20071361808617222197
   PubMed Web of Science ®Google Scholar
• SchopRFKuehlWMVan WierSAWaldenström macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletionsBlood200210082996300112351413
   PubMed Web of Science ®Google Scholar
• ChangHQiXXuWReaderJCNingYAnalysis of 6q deletion in Waldenstrom macroglobulinemiaEur J Haematol200779324424717655703
   PubMed Web of Science ®Google Scholar
• SchopRFVan WierSAXuR6q deletion discriminates Waldenström macroglobulinemia from IgM monoclonal gammopathy of undetermined significanceCancer Genet Cytogenet2006169215015316938573
   PubMedGoogle Scholar
• FerreiraBIGarcíaJFSuelaJComparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasiaHaematologica200893567067918367492
   PubMed Web of Science ®Google Scholar
• PoulainSBraggioERoumierCHigh-throughput genomic analysis in Waldenström’s macroglobulinemiaClin Lymphoma Myeloma Leuk201111110610821454205
   PubMed Web of Science ®Google Scholar
• TurnerCAJrMackDHDavisMMBlimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cellsCell19947722973068168136
   PubMed Web of Science ®Google Scholar
• CalameKLLinKITunyaplinCRegulatory mechanisms that determine the development and function of plasma cellsAnnu Rev Immunol20032120523012524387
   PubMed Web of Science ®Google Scholar
• ShafferALShapiro-ShelefMIwakoshiNNXBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiationImmunity2004211819315345222
   PubMed Web of Science ®Google Scholar
• KellerADManiatisTOnly two of the five zinc fingers of the eukaryotic transcriptional repressor PRDI-BF1 are required for sequence-specific DNA bindingMol Cell Biol1992125194019491569931
   PubMed Web of Science ®Google Scholar
• RenBCheeKJKimTHManiatisTPRDI-BF1/Blimp-1 repression is mediated by corepressors of the Groucho family of proteinsGenes Dev19991311251379887105
   PubMed Web of Science ®Google Scholar
• GyöryIFejérGGhoshNSetoEWrightKLIdentification of a functionally impaired positive regulatory domain I binding factor 1 transcription repressor in myeloma cell linesJ Immunol200317063125313312626569
   PubMed Web of Science ®Google Scholar
• BasakGWSrivastavaASMalhotraRCarrierEMultiple myeloma bone marrow nicheCurr Pharm Biotechnol200910334534619355944
   PubMed Web of Science ®Google Scholar
• DanbaraMKameyamaKHigashiharaMTakagakiYDNA methylation dominates transcriptional silencing of Pax5 in terminally differentiated B cell linesMol Immunol200238151161116612044782
   PubMed Web of Science ®Google Scholar
• ShafferALLinKIKuoTCBlimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression programImmunity2002171516212150891
   PubMed Web of Science ®Google Scholar
• NeraKPKohonenPNarviELoss of Pax5 promotes plasma cell differentiationImmunity200624328329316546097
   PubMed Web of Science ®Google Scholar
• UrbánekPWangZQFetkaIWagnerEFBusslingerMComplete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAPCell19947959019128001127
   PubMed Web of Science ®Google Scholar
• MikkolaIHeaveyBHorcherMBusslingerMReversion of B cell commitment upon loss of Pax5 expressionScience2002297557811011312098702
   PubMed Web of Science ®Google Scholar
• LinKIAngelin-DuclosCKuoTCCalameKBlimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cellsMol Cell Biol200222134771478012052884
   PubMed Web of Science ®Google Scholar
• WalterPRonDThe unfolded protein response: from stress pathway to homeostatic regulationScience201133460591081108622116877
   PubMed Web of Science ®Google Scholar
• ReimoldAMIwakoshiNNManisJPlasma cell differentiation requires the transcription factor XBP-1Nature2001412684430030711460154
   PubMed Web of Science ®Google Scholar
• PiskurichJFLinKILinYWangYTingJPCalameKBLIMP-I mediates extinction of major histocompatibility class II transactivator expression in plasma cellsNat Immunol20001652653211101876
   PubMed Web of Science ®Google Scholar
• LinYWongKCalameKRepression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiationScience199727653125965999110979
   PubMed Web of Science ®Google Scholar
• VrzalikovaKWoodmanCBMurrayPGBLIMP1α, the master regulator of plasma cell differentiation is a tumor supressor gene in B cell lymphomasBiomed Pap Med Fac Univ Palacky Olomouc Czech Repub201215611622580854
   PubMed Web of Science ®Google Scholar
• HymowitzSGWertzIEA20: from ubiquitin editing to tumour suppressionNat Rev Cancer201010533234120383180
   PubMed Web of Science ®Google Scholar
• MaAMalynnBAA20: linking a complex regulator of ubiquitylation to immunity and human diseaseNat Rev Immunol2012121177478523059429
   PubMed Web of Science ®Google Scholar
• WertzIEO’RourkeKMZhouHDe-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signallingNature2004430700069469915258597
   PubMed Web of Science ®Google Scholar
• ShembadeNHarhajEWRegulation of NF-κB signaling by the A20 deubiquitinaseCell Mol Immunol20129212313022343828
   PubMed Web of Science ®Google Scholar
• ShembadeNMaAHarhajEWInhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexesScience201032759691135113920185725
   PubMed Web of Science ®Google Scholar
• SkaugBChenJDuFHeJMaAChenZJDirect, noncatalytic mechanism of IKK inhibition by A20Mol Cell201144455957122099304
   PubMed Web of Science ®Google Scholar
• SunSCNon-canonical NF-κB signaling pathwayCell Res2011211718521173796
   PubMed Web of Science ®Google Scholar
• RazaniBReichardtADChengGNon-canonical NF-κB signaling activation and regulation: principles and perspectivesImmunol Rev20112441445422017430
   PubMed Web of Science ®Google Scholar
• BraggioEKeatsJJLeleuXIdentification of copy number abnormalities and inactivating mutations in two negative regulators of nuclear factor-kappaB signaling pathways in Waldenstrom’s macroglobulinemiaCancer Res20096983579358819351844
   PubMed Web of Science ®Google Scholar
• TreonSPXuLYangGMYD88 L265P somatic mutation in Waldenström’s macroglobulinemiaN Engl J Med2012367982683322931316
   PubMed Web of Science ®Google Scholar
• MuzioMNiJFengPDixitVMIRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signalingScience19972785343161216159374458
   PubMed Web of Science ®Google Scholar
• WescheHHenzelWJShillinglawWLiSCaoZMyD88: an adapter that recruits IRAK to the IL-1 receptor complexImmunity1997768378479430229
   PubMed Web of Science ®Google Scholar
• LinSCLoYCWuHHelical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signallingNature2010465730088589020485341
   PubMed Web of Science ®Google Scholar
• HataoFYamamotoMMuroiMKaminishiMTanamotoKMyD88-induced downregulation of IRAK-4 and its structural requirementsFEMS Immunol Med Microbiol200853226026418503546
   PubMedGoogle Scholar
• NgoVNYoungRMSchmitzROncogenically active MYD88 mutations in human lymphomaNature2011470733211511921179087
   PubMed Web of Science ®Google Scholar
• XuLHunterZRYangGMYD88 L265P in Waldenstrom’s macroglobulinemia, IgM monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific PCRBlood Epub1152013
   Web of Science ®Google Scholar
• GachardNParrensMSoubeyranIIGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomasLeukemia201327118318922944768
   PubMed Web of Science ®Google Scholar
• KongYWFerland-McColloughDJacksonTJBushellMmicroRNAs in cancer managementLancet Oncol2012136e2495822652233
   PubMed Web of Science ®Google Scholar
• RoccaroAMSaccoAChenCmicroRNA expression in the biology, prognosis, and therapy of Waldenström macroglobulinemiaBlood2009113184391440219074725
   PubMed Web of Science ®Google Scholar
• HuangXShenYLiuMQuantitative proteomics reveals that miR-155 regulates the PI3K-AKT pathway in diffuse large B-cell lymphomaAm J Pathol20121811263322609116
   PubMed Web of Science ®Google Scholar
• KimJHKimWSParkCEpstein-Barr virus latent membrane protein-1 protects B-cell lymphoma from rituximab-induced apoptosis through miR-155-mediated Akt activation and up-regulation of Mcl-1Leuk Lymphoma20125381586159122268450
   PubMed Web of Science ®Google Scholar
• ThompsonRCHerscovitchMZhaoIFordTJGilmoreTDNF-kappaB down-regulates expression of the B-lymphoma marker CD10 through a miR-155/PU.1 pathwayJ Biol Chem201128631675168220947507
   PubMed Web of Science ®Google Scholar
• YamanakaYTaqawaHTakahashiNAberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemiaBlood2009114153265327519641183
   PubMed Web of Science ®Google Scholar
• ZhangYRoccaroAMRombaoaCLNA-mediated anti-miR-155 silencing in low-grade B-cell lymphomasBlood201212081678168622797699
   PubMed Web of Science ®Google Scholar
• SaccoAIssaGCZhangYEpigenetic modifications as key regulators of Waldenstrom’s Macroglobulinemia biologyJ Hematol Oncol201033820929526
   PubMed Web of Science ®Google Scholar
• SaccoAGhobrialIMRoccaroAMEpigenetics in Waldenström’s macroglobulinemiaEpigenomics20102569169622122052
   PubMed Web of Science ®Google Scholar
• CalinGADumitruCDShimizuMFrequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemiaProc Natl Acad Sci USA20029924155241552912434020
   PubMed Web of Science ®Google Scholar
• CalinGACimminoAFabbriMMiR-15a and miR-16–1 cluster functions in human leukemiaProc Natl Acad Sci USA2008105135166517118362358
   PubMed Web of Science ®Google Scholar